Back to User profile » Dr Yu Pang

Papers published by Dr Yu Pang:


Drug Exposure Dictates Evolutionary Dynamics of Drug-Resistant Tuberculosis: A Longitudinal Cohort Study in Beijing, China

Wen S, Li H, Shi Y, Wei R, Ge F, Pang Y, Liu Y

Infection and Drug Resistance 2026, 19:580421

Published Date: 23 March 2026

Identification of a Four-Biomarker Panel for the Diagnosis of Tuberculous Pleural Effusion Using Olink Proteomics

Xing X, Guo C, Zhao G, Xie D, Zhang L, Shi K, Zhang Z, Pang Y, Cui J

Journal of Inflammation Research 2026, 19:575888

Published Date: 20 March 2026

Glucose Metabolic Reprogramming of Macrophages Against Mycobacterium tuberculosis Infection

Liu T, Yang Z, Tong J, Gao M, Pang Y

ImmunoTargets and Therapy 2025, 14:1209-1221

Published Date: 31 October 2025

Regulatory Mechanisms of Co-Inhibitory Receptors in Tuberculosis Immunity: Implications for Therapeutic Targets

Liu H, Li H, Li S, Shang Y, Tang S, Pang Y

ImmunoTargets and Therapy 2025, 14:1169-1185

Published Date: 24 October 2025

Mitophagy: A Potential Therapeutic Target for Tuberculosis Immunotherapy

Gao S, Yang Z, Yu J, Zhang F, Tang S, Pang Y

ImmunoTargets and Therapy 2025, 14:773-786

Published Date: 22 July 2025

Attenuated Cytokine-Induced Memory-Like Natural Killer Cell Responses to Mycobacterium tuberculosis in Tuberculosis Patients

Liang C, Li S, Yuan J, Song Y, Ren W, Wang W, Shang Y, Tang S, Pang Y

Infection and Drug Resistance 2023, 16:2349-2364

Published Date: 20 April 2023

Serum Cytokine Biomarkers for Use in Diagnosing Pulmonary Tuberculosis versus Chronic Pulmonary Aspergillosis

Ren W, Li H, Guo C, Shang Y, Wang W, Zhang X, Li S, Pang Y

Infection and Drug Resistance 2023, 16:2217-2226

Published Date: 14 April 2023

Antimicrobial Effect of Oxazolidinones and Its Synergistic Effect with Bedaquiline Against Mycobacterium abscessus Complex

Gao T, Yao C, Shang Y, Su R, Zhang X, Ren W, Li S, Shu W, Pang Y, Li Q

Infection and Drug Resistance 2023, 16:279-287

Published Date: 14 January 2023

The Emergence of Novel Spoligotypes of Highly Drug-Resistant Mycobacterium tuberculosis Isolates in Fujian, China

Lin S, Wei S, Zhao Y, Dai Z, Lin J, Pang Y

Infection and Drug Resistance 2022, 15:5781-5793

Published Date: 1 October 2022

A Peptidomic Approach to Identify Novel Antigen Biomarkers for the Diagnosis of Tuberculosis

Chen H, Li S, Zhao W, Deng J, Yan Z, Zhang T, Wen SA, Guo H, Li L, Yuan J, Zhang H, Ma L, Zheng J, Gao M, Pang Y

Infection and Drug Resistance 2022, 15:4617-4626

Published Date: 18 August 2022

Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China

Zhang Z, Wang W, Wang Y, Xue Z, Li S, Pang Y

Infection and Drug Resistance 2022, 15:2287-2291

Published Date: 28 April 2022

Genetic Diversity and Drug Susceptibility Profiles of Multidrug-Resistant Tuberculosis Strains in Southeast China

Lin S, Wei S, Zhao Y, Dai Z, Lin J, Pang Y

Infection and Drug Resistance 2021, 14:3979-3989

Published Date: 28 September 2021

Dependence of Xpert MTB/RIF Accuracy for Detecting Rifampin Resistance in Bronchoalveolar Lavage Fluid on Bacterial Load: A Retrospective Study in Beijing, China

Qin L, Huo F, Ren W, Shang Y, Yao C, Zhang X, Liu R, Ma L, Gao M, Pang Y

Infection and Drug Resistance 2021, 14:2429-2435

Published Date: 28 June 2021

Diagnostic Yield of Oral Swab Testing by TB-LAMP for Diagnosis of Pulmonary Tuberculosis

Song Y, Ma Y, Liu R, Shang Y, Ma L, Huo F, Li Y, Shu W, Wang Y, Gao M, Pang Y

Infection and Drug Resistance 2021, 14:89-95

Published Date: 12 January 2021

Rapid Detection of Ethambutol-Resistant Mycobacterium tuberculosis from Sputum by High-Resolution Melting Analysis in Beijing, China

Wang J, Zhao W, Liu R, Huo F, Dong L, Xue Y, Wang Y, Xue Z, Ma L, Pang Y

Infection and Drug Resistance 2020, 13:3707-3713

Published Date: 20 October 2020

Rapid Diagnosis Of Multidrug-Resistant Tuberculosis Impacts Expenditures Prior To Appropriate Treatment: A Performance And Diagnostic Cost Analysis

Li X, Deng Y, Wang J, Jing H, Shu W, Qin J, Pang Y, Ma X

Infection and Drug Resistance 2019, 12:3549-3555

Published Date: 14 November 2019

Successful management of Mycobacterium abscessus complex lung disease in an otherwise healthy infant

Liu H, Dong F, Liu J, Liu J, Pang Y, Zhao S, Lu J, Li H

Infection and Drug Resistance 2019, 12:1277-1283

Published Date: 15 May 2019

Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis

Zhang T, Jiang G, Wen S, Huo F, Wang F, Huang H, Pang Y

Infection and Drug Resistance 2019, 12:825-829

Published Date: 11 April 2019

Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China

Wang J, Pang Y, Jing W, Chen W, Guo R, Han X, Wu L, Yang G, Yang K, Chen C, Jiang L, Cai C, Dou Z, Diao L, Pan H, Wang J, Du F, Xu T, Wang L, Li R, Chu N

Infection and Drug Resistance 2019, 12:763-770

Published Date: 3 April 2019

Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones

Tang P, Xu P, Shu W, Wang X, Guo J, Song H, Li S, Pang Y, Wu M

Infection and Drug Resistance 2019, 12:87-93

Published Date: 27 December 2018